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expression and synthesis of NF-κB inhibitors, IκBα and I-κB-β.
(4) DTF downregulates IL-1β-induced IκB kinase (IKK) activation
in cells treated with DTF/rest for 4/20, 8/16, 12/12, and 16/8.
Conclusions: This is the ﬁrst study to demonstrate persistent
effects of biomechanical signals in the surrounding proinﬂamma-
tory environment. Furthermore, biomechanical signals suppress
NF-kB signaling cascade. These signals act in two ways: (i) in-
hibit mRNA expression and synthesis of NF-κB, I-κBα and I-κBβ,
and (ii) downregulate IKKb activation and thus I-κB degradation.
The studies show the necessity of using adequate time intervals
of physical therapies for the optimal management of arthritic
joints.
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ACTIVIN A IS AN ANTI-CATABOLIC CYTOKINE
PRODUCED BY INJURED CARTILAGE VIA RELEASE OF
FIBROBLAST GROWTH FACTOR-2 AND ACTIVATION OF
NUCLEAR FACTOR KAPPA B
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J. Saklatvala1
1Kennedy Institute of Rheumatology, Imperial College, London,
United Kingdom; 2Karolinsksa Institute, Stockholm, Sweden
Purpose: Direct or indirect injuries to articular cartilage predis-
pose to osteoarthritis. We have previously shown that injury to
cartilage such as simple dissection causes the release of FGF-2
from a pericellular pool and activation of inﬂammatory signalling
pathways such as the mitogen activated protein kinases and
NFκB. Following such injury, the TGF β family member activin
A is synthesised by human articular cartilage. We investigated
a) how injury regulates the production of activin A by articular
cartilage and b) whether this molecule has an important function
in cartilage. Because TGF β has anti-inﬂammatory actions, the
effect of activin A on IL-1-induced breakdown of the proteoglycan
aggrecan in cartilage was assessed.
Methods: Activin A production was measured by ELISA of
porcine or human cartilage explant culture medium. mRNA in-
duction in cartilage explants or primary chondrocyte monolayers
was by RT-PCR for genes of interest. The effect of exogenous
activin A on IL-1 induced cleavage of aggrecan was determined
by western blotting medium from human cartilage explant culture
for the aggrecan cleavage neoepitope ARGSV.
Results: Activin A mRNA and protein were induced by sim-
ple dissection of human or porcine cartilage from the articular
surface. Its production was due to an active cellular process.
Activin A mRNA in cartilage explants was induced by FGF-2.
Activin A production following injury was reduced by 80% by the
FGF receptor inhibitor PD173074 and 70% by the IKK inhibitor
BMS345541. FGF appeared to induce activin A production via
ERK and src family kinases. Low concentrations of exogenous
activin A suppressed the IL-1 induced aggrecanase-mediated
cleavage of aggrecan in human articular cartilage. Osteoarthritic
cartilage was noted to produce signiﬁcantly more activin A than
normal cartilage.
Conclusions:Activin A is produced by chondrocytes in response
to injury of articular cartilage in an FGF and NFκB-dependent
manner. This molecule appears to be anti-catabolic for carti-
Abstract 160 – Table 1
Day 5 Day 9 Day 13
GAGs (µg)/DNA (µg) GAGs (µg)/DNA (µg) GAGs (µg)/DNA (µg)
(n) (n) (n)
Non-Obese Group (BMI < 30 kg/m2) 31.8 (3) 53.3 (6) 34.9 (2)
Obese Group (BMI > 30 kg/m2) 140.6 (6) 205.6 (6) 323.8 (3)
lage by preventing aggrecan breakdown, and its production is
enhanced in osteoarthritic tissue. Activin A may therefore be an
endogenous chondroprotective cytokine, whose actions might be
exploited therapeutically.
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Purpose: Osteoarthritis (OA) is the most common form of arthri-
tis in the United States and has been linked to obesity. It is
hypothesized that obesity, deﬁned as a body mass index (BMI)
over 30 kg/m2, increases the incidence of OA through increased
joint pressure and disruption of normal metabolism. Studies have
identiﬁed factors in obese patients that may function as regula-
tors of chondrocyte metabolism. However, metabolic changes
resulting from obesity that may precede OA have not been thor-
oughly investigated. The purpose of this study was to identify
the relationship between chondrocyte metabolism and BMI in
osteoarthritic tissue.
Methods: Grade 0 or 1 cartilage was removed from the me-
dial and/or lateral femoral condyles after total knee arthroplasty
and was digested in collagenase. The chondrocytes were then
resuspended in alginate beads at 2x106 cells/mL. The beads
were equilibrated in media containing 10% fetal bovine serum
for 7 days (37°C) and then separated into wells (8 beads/well)
with 1 mL media. Media was replaced every 48 hours. At day
5, 9, and 13, beads were dissolved in 55 mM sodium citrate
and centrifuged into their cell matrix and alginate portions. Gly-
cosaminoglycan (GAG) content was measured in the cell pellet,
alginate, and saved media using the dimethylmethylene blue
(DMMB) assay. The DMMB results were normalized to DNA con-
tent. To assess differences in GAG content between obese and
non-obese group, a Wilcoxon rank sum test was used. P < 0.05
was used as the criterion for signiﬁcance. All procedures were
approved by the University of Wisconsin - Madison, Institutional
Review Board.
Results: At day 5, the average normalized GAGs from the obese
group (BMI >30 kg/m2) was >4-fold higher than the average
normalized GAGs in the non-obese group (BMI <30 kg/m2).
Table 1 displays the normalized GAG averages from the 3 study
days.
Fig. 1 shows a signiﬁcant and linear relationship between BMI
and normalized GAGs at day 9 (p=0.0003).
The 4-fold difference in normalized GAGs between obese
and non-obese groups continued at day 9 with signiﬁcance
(p=0.0087) and widened at day 13, without signiﬁcance. Fig. 2
displays the day 9 averages of normalized GAG content from the
obese and non-obese groups.
Some osteoarthritic knees had less tissue quality, therefore GAG
testing was limited to earlier study days resulting in variable
sample numbers for each study day.
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Figure 1
Figure 2
Conclusions: The study results reveal a signiﬁcant relationship
between normalized GAGs and BMI in this population of os-
teoarthritic patients. Higher patient BMI (>30 kg/m2) may be
similar to dynamic compression injuries that cause increased
GAG synthesis in response to cartilage damage. The lack of
signiﬁcance at day 5 and 13 may be the result of OA tissue
variability and signiﬁcance may be achieved with increased sam-
ple numbers. In conclusion, elevated normalized GAGs in obese
patients’ chondrocytes suggests increased cartilage damage.
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THE EXPRESSION OF NOTCH SIGNALING
COMPONENTS IN OSTEOARTHRITIS
P.G. Alexander, S.M. Koehler, R.S. Tuan
National Institutes of Health, Bethesda, MD
Purpose: This study aims to investigate the role of Notch sig-
naling in the pathogenesis of osteoarthritis (OA). The Notch sig-
naling pathway is a highly conserved signaling system that plays
a critical role in cell proliferation, differentiation, and apoptosis
in the context of stem cell differentiation. Thus, aberrant regula-
tion of Notch signaling may adversely affect cartilage repair by
altering chondrogenesis of mesenchymal stem cells (MSCs) in
diseased tissue.
Methods: Human OA cartilage was obtained from surgical waste
material following total knee arthroplasty or from normal joint tis-
sue (from the National Disease Research Interchange). Human
chondrocytes (hCh) and bone marrow MSCs were isolated using
established methods. Quantitative RT-PCR was utilized to ana-
lyze transcript levels of Notch signaling components in OA and
normal tissue and monolayer cultures of hChs and MSCs. His-
tological staining was performed with H&E, alcian blue, alizarin
red, Fast Green, and Safarin O. MSCs and hChs were cultured
in high-density pellets in serum-free chondrogenic medium. To
mimic OA conditions, pellets cultures were treated with 0.1 ng/mL
IL-1β for 21 days. Harvested pellets were analyzed histologically
and for gene expression as described above.
Results: Expression of Notch1, Notch2, Jagged1, and Delta1 is
down regulated in OA compared to normal cartilage 200-, 12-,
34-, and 30-fold, respectively (Fig. 1). Notch1 expression is highly
expressed in normal cartilage, absent in monolayer hChs, and
similarly expressed in monolayer MSCs and OA cartilage. During
MSC chondrogenesis in vitro, Notch1 is down regulated in the
IL-1β treated cultures compared to expression in the untreated
cultures at days 7 and 21 (5- and 65-fold, respectively) (Fig. 2).
Notch2, Notch3, Jagged1, and Delta1 expression decrease from
day 7 to 21 with or without IL-1β treatment. In addition, Sox9
is also down regulated in the treated compared to untreated
cultures at days 7 and 21 (18- and 5-fold, respectively) (Fig. 3).
In comparison, during chondrogenesis of hChs in vitro, Notch1
increases in untreated cultures from day 7 to 21 (5-fold), but is
unexpressed in day 21 IL-1β treated hChs (Fig. 2). All Notch
components are expressed at lower levels in untreated hChs
compared to treated. Overall, chondrogenesis gene expression
was down regulated in IL-1β treated cultures (Fig. 3).
Conclusions: The down regulation of notch components in OA
cartilage suggests that its poor regenerative capacity may be
related in part to reduced chondrogenic differentiation of chon-
droprogenitor cells. Support is provided from the results of the
MSC in vitro chrondrogenesis study - under OA conditions, i.e.,
IL-1β treatment, Notch expression is down regulated and chron-
drogenesis is impaired. For hChs, in vitro chondrogenesis is
accompanied by increased Notch expression, whereas chon-
drogenesis gene expression is decreased under OA conditions.
Therefore, hChs appear to dedifferentiate and are prevented to
undergo chondrogenesis in the presence of IL-1β. Similar cellu-
lar reactions may also take place under OA conditions in vivo,
resulting in a decrease of hChs and MSCs able to undergo
chrondrogenesis; instead, the cells may differentiate into alterna-
